Induction and maintenance of SARS-CoV-2 mRNA vaccine-specific memory across tissues
Induction and maintenance of SARS-CoV-2 mRNA vaccine-specific memory across tissues
批准号:
10751246
负责人:
Julia Meghan Davis-Porada
金额:
$4.92万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-07-01 至 2027-06-30
关键词:
2019-nCoVAdultAffectAgeAntibody FormationAntibody titer measurementAttenuatedAuthorization documentationB-LymphocytesBloodBlood specimenCOVID-19 pandemicCOVID-19 vaccineCell physiologyCellsChildClinicalCollaborationsCommunitiesDataDevelopmentEnzyme-Linked Immunosorbent AssayEventExhibitsFlow CytometryFrequenciesFutureGoalsHealthHumanHumoral ImmunitiesImmuneImmune responseImmune systemImmunityImmunologic MemoryIndividualInfectionInflammatoryIntegration Host FactorsInterferonsInvestigationKnowledgeLaboratoriesLifeLungLymphocyteLymphoidLymphoid TissueMacrophageMaintenanceMeasuresMediatingMedicalMemoryMemory B-LymphocyteModelingModerna COVID-19 vaccineMonitorMononuclearMorbidity - disease rateMucous MembraneNatural ImmunityOrgan DonorOrgan ProcurementsOutcomePersonsPhenotypePopulationPrevention strategyProductionPropertyProteinsRNA vaccineResidenciesResourcesRoleSerologySiteSpatial DistributionT memory cellT-LymphocyteTimeTissue DonorsTissuesVaccinatedVaccinationVaccine DesignVaccineeVaccinesVariantViralVirusVirus DiseasesWorkadaptive immunityauthoritycoronavirus diseasecurrent pandemiccytokinefrontierhigh dimensionalityhuman tissueimprovedlymph nodeslymphoid organmanufacturemortalityneutralizing antibodynovelnovel vaccinespandemic diseasepathogenpreventquantitative imagingrespiratory virusresponsesevere COVID-19tissue resourceunvaccinatedvaccine developmentvaccine distributionvaccine efficacyvaccine formulationvaccine responsevaccine strategyvaccine trialvaccine-induced immunityvaccinology
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Vaccines save lives, and the rapid development of novel vaccines against severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2) was a triumph for the medical community. While the rapid deployment of these
vaccines has undoubtedly attenuated the severe morbidity and mortality induced by the virus, their efficacy is
decreased against variant strains, in children, and with increasing time post-administration. These clinical
findings highlight our lack of understanding of how durable, protective immunity is induced by vaccination and
how this varies across the population. Studying vaccine induced memory in humans has two major challenges.
First, viral exposures over life confound the identification of vaccine-specific memory; second, the stores of
memory lymphocytes reside in the tissues, which makes monitoring the vaccine response in healthy individuals
challenging. The SARS-CoV-2 pandemic affords us the unique opportunity to study the response to a novel
vaccine formulation without confounding natural antigenic exposure and the ability to distinguish infection from
vaccination by serology. Additionally, our unique organ donor tissue resource provides a validated model to
investigate tissue-localized vaccine-specific immunity. The goal of this proposal is to understand how vaccine-
induced immune memory is distributed across tissue and affected by host factors such as age. The central
hypothesis of this proposal is that induction and maintenance of vaccine-specific memory is controlled in
lymph nodes, and specific early induction events directly impact immune memory development and
vary with age. I will address this hypothesis and meet the goals of the study by using flow cytometry and high-
dimensional sequencing to evaluate the relationship between circulating and tissue-localized vaccine memory
and how they differ in phenotype, function, and across age. I will also investigate how the initial, inflammatory
host-specific response to the mRNA-1273 vaccine differs across age and correlates to the quantity of immune
memory induced. The results of this study will elucidate the importance of lymph nodes in the vaccine
response and highlight the benefits and downfalls of mRNA vaccines across various host factors. These
results will have implications for future vaccine design and may play a role in managing both the SARS-CoV-2
pandemic and any future ones.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金